Zoledronic Acid (hydrate)

A bisphosphonate that inhibits bone resorption

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
25mg

￥950.00

760.00

- +
50mg

￥987.00

790.00

- +
100mg

￥1900.00

1520.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci74616
CAS: 165800-06-6
别名: 唑来膦酸一水合物; Zoledronate monohydrate; CGP 42446 monohydrate; CGP42446A monohydrate; ZOL 446 monohydrate
分子式: C5H10N2O7P2?H2O
分子量: 290.1
纯度: >98%
溶解度: PBS (pH 7.2): 1.6 mg/ml
储存: Store at -20°C
库存: 现货

Background

Zoledronic acid is a third-generation heterocyclic nitrogen-containing bisphosphonate that inhibits the prenylation of GTPases critical to the signaling events related to osteoclast-mediated bone resorption. It has a high affinity for hydroxyapatite (Ki = 3.47 μM) and binds directly to mineralized bone where it decreases bone resorption by inhibiting osteoclast proliferation and inducing osteoclast apoptosis. At μM concentrations, zoledronic acid demonstrates antitumor effects in vitro against breast, prostate, and myeloma cancer cells by inducing cytostasis and prevents bone metastases through its inhibitory effects on adhesion molecules, tumor cell invasion, and angiogenesis. Zoledronic acid has been used in the treatment of osteoporosis, Paget's disease, metastatic bone disease, multiple myeloma, hypercalcemia of malignancy, and skeletal-related events associated with metastatic castrate-resistant prostate cancer.